{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:25:31Z","timestamp":1786926331872,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR079424"],"award-info":[{"award-number":["R01AR079424"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["F31AR082284"],"award-info":[{"award-number":["F31AR082284"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM007356"],"award-info":[{"award-number":["T32GM007356"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM135134"],"award-info":[{"award-number":["T32GM135134"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003975","name":"Myotonic Dystrophy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["T90DE021985"],"award-info":[{"award-number":["T90DE021985"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["470092532"],"award-info":[{"award-number":["470092532"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A cardinal sign of myotonic dystrophy type 1 (DM1) is myotonia, slow muscle relaxation after voluntary contraction. Myotonia results from mis-regulated splicing of chloride channel 1 (ClC-1), leading to loss of channel function and runs of involuntary action potentials in muscle fibers. Preceding the onset of weakness, myotonia is often the first symptom of DM1, and thus this raises the possibility that muscle hyperexcitability contributes to the subsequent weakness and myopathy. Here, we show that genomic deletion of ClC-1 exon 7a (E7a), a cryptic exon abnormally regulated in DM1, completely rescues of ClC-1 function and yields permanent elimination of myotonia in the muscleblind-like 1 (Mbnl1) knockout mouse model of DM1. The restoration of normal excitability results in normalization of muscle force generation, correction of fiber-type distribution, and improvement of muscle histology. E7a deletion also partially corrects the muscle transcriptome, including changes of differential gene expression and alternative splicing. These results indicate that E7a inclusion is a lynchpin splice event that contributes to myotonic myopathy, and support myotonia reduction as a therapeutic objective in DM1.<\/jats:p>","DOI":"10.1038\/s41467-026-75243-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:26:02Z","timestamp":1783513562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elimination of myotonia improves myopathy in a muscleblind-like knockout model of myotonic dystrophy"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3194-2661","authenticated-orcid":false,"given":"Matthew T.","family":"Sipple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura A.","family":"Hamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Todorow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily A.","family":"Cisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Lupia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-8800","authenticated-orcid":false,"given":"Christina S.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3359-3837","authenticated-orcid":false,"given":"Peter","family":"Meinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1820-711X","authenticated-orcid":false,"given":"John D.","family":"Lueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"75243_CR1","unstructured":"Harper, P. S. Myotonic Dystrophy (W. B., Saunders Company, 2001)."},{"key":"75243_CR2","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1093\/emboj\/19.17.4439","volume":"19","author":"JW Miller","year":"2000","unstructured":"Miller, J. W. et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J. 19, 4439\u20134448 (2000).","journal-title":"EMBO J."},{"key":"75243_CR3","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1126\/science.1088583","volume":"302","author":"RN Kanadia","year":"2003","unstructured":"Kanadia, R. N. et al. A muscleblind knockout model for myotonic dystrophy. Science 302, 1978\u20131980 (2003).","journal-title":"Science"},{"key":"75243_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.molcel.2014.08.027","volume":"56","author":"R Batra","year":"2014","unstructured":"Batra, R. et al. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell 56, 311\u2013322 (2014).","journal-title":"Mol. Cell"},{"key":"75243_CR5","doi-asserted-by":"publisher","first-page":"a000778","DOI":"10.1101\/cshperspect.a000778","volume":"3","author":"MG Poulos","year":"2011","unstructured":"Poulos, M. G., Batra, R., Charizanis, K. & Swanson, M. S. Developments in RNA splicing and disease. Cold Spring Harb. Perspect. Biol. 3, a000778 (2011).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"75243_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mus.20722","volume":"35","author":"EL Logigian","year":"2007","unstructured":"Logigian, E. L. et al. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 35, 479\u2013485 (2007).","journal-title":"Muscle Nerve"},{"key":"75243_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1212\/WNL.0b013e318260cbe6","volume":"79","author":"C Heatwole","year":"2012","unstructured":"Heatwole, C. et al. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology 79, 348\u2013357 (2012).","journal-title":"Neurology"},{"key":"75243_CR8","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1172\/JCI128205","volume":"129","author":"AF Klein","year":"2019","unstructured":"Klein, A. F. et al. Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice.  J. Clin. Invest. 129, 4739\u20134744 (2019).","journal-title":"J. Clin. Invest."},{"key":"75243_CR9","doi-asserted-by":"publisher","unstructured":"Cisco, L. A., Sipple, M. T., Edwards, K. M., Thornton, C. A. & Lueck, J. D. Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model. J. Clin. Invest. 134, https:\/\/doi.org\/10.1172\/JCI173576 (2024).","DOI":"10.1172\/JCI173576"},{"key":"75243_CR10","doi-asserted-by":"publisher","unstructured":"Provenzano, M. et al. The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1. J. Clin. Invest. 135, https:\/\/doi.org\/10.1172\/JCI185426 (2025).","DOI":"10.1172\/JCI185426"},{"key":"75243_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ceca.2008.11.005","volume":"45","author":"T Kimura","year":"2009","unstructured":"Kimura, T. et al. Alternative splicing of RyR1 alters the efficacy of skeletal EC coupling. Cell Calcium 45, 264\u2013274 (2009).","journal-title":"Cell Calcium"},{"key":"75243_CR12","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/hmg\/ddi223","volume":"14","author":"T Kimura","year":"2005","unstructured":"Kimura, T. et al. Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic\/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1. Hum. Mol. Genet. 14, 2189\u20132200 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"75243_CR13","doi-asserted-by":"publisher","first-page":"C1291","DOI":"10.1152\/ajpcell.00336.2006","volume":"292","author":"JD Lueck","year":"2007","unstructured":"Lueck, J. D. et al. Chloride channelopathy in myotonic dystrophy resulting from loss of posttranscriptional regulation for CLCN1. Am. J. Physiol. Cell Physiol. 292, C1291\u2013C1297 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"75243_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1085\/jgp.200609635","volume":"129","author":"JD Lueck","year":"2007","unstructured":"Lueck, J. D., Mankodi, A., Swanson, M. S., Thornton, C. A. & Dirksen, R. T. Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy. J. Gen. Physiol. 129, 79\u201394 (2007).","journal-title":"J. Gen. Physiol."},{"key":"75243_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1097-2765(02)00563-4","volume":"10","author":"A Mankodi","year":"2002","unstructured":"Mankodi, A. et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10, 35\u201344 (2002).","journal-title":"Mol. Cell"},{"key":"75243_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S1097-2765(02)00572-5","volume":"10","author":"N Charlet-B","year":"2002","unstructured":"Charlet-B, N. et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10, 45\u201353 (2002).","journal-title":"Mol. Cell"},{"key":"75243_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/hmg\/ddr568","volume":"21","author":"ZZ Tang","year":"2012","unstructured":"Tang, Z. Z. et al. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum. Mol. Genet. 21, 1312\u20131324 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"75243_CR18","first-page":"1547","volume":"143","author":"N Sultana","year":"2016","unstructured":"Sultana, N. et al. Restricting calcium currents is required for correct fiber type specification in skeletal muscle. Development 143, 1547\u20131559 (2016).","journal-title":"Development"},{"key":"75243_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bpj.2008.09.027","volume":"96","author":"P Tuluc","year":"2009","unstructured":"Tuluc, P. et al. A CaV1.1 Ca2+ channel splice variant with high conductance and voltage-sensitivity alters EC coupling in developing skeletal muscle. Biophys. J. 96, 35\u201344 (2009).","journal-title":"Biophys. J."},{"key":"75243_CR20","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00415-013-6993-0","volume":"260","author":"JE Hilbert","year":"2013","unstructured":"Hilbert, J. E. et al. Diagnostic odyssey of patients with myotonic dystrophy. J. Neurol. 260, 2497\u20132504 (2013).","journal-title":"J. Neurol."},{"key":"75243_CR21","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.1093\/nar\/gkp681","volume":"37","author":"Y Kino","year":"2009","unstructured":"Kino, Y. et al. MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res. 37, 6477\u20136490 (2009).","journal-title":"Nucleic Acids Res."},{"key":"75243_CR22","first-page":"3952","volume":"117","author":"TM Wheeler","year":"2007","unstructured":"Wheeler, T. M., Lueck, J. D., Swanson, M. S., Dirksen, R. T. & Thornton, C. A. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 117, 3952\u20133957 (2007).","journal-title":"J. Clin. Invest."},{"key":"75243_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37619-1","volume":"14","author":"N Hu","year":"2023","unstructured":"Hu, N., Kim, E., Antoury, L. & Wheeler, T. M. Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy. Nat. Commun. 14, 1956 (2023).","journal-title":"Nat. Commun."},{"key":"75243_CR24","first-page":"6211","volume":"13","author":"O Kessler","year":"1993","unstructured":"Kessler, O., Jiang, Y. & Chasin, L. A. Order of intron removal during splicing of endogenous adenine phosphoribosyltransferase and dihydrofolate reductase pre-mRNA. Mol. Cell. Biol. 13, 6211\u20136222 (1993).","journal-title":"Mol. Cell. Biol."},{"key":"75243_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0551-7","volume":"15","author":"Z Wang","year":"2014","unstructured":"Wang, Z., Murigneux, V. & Le Hir, H. Transcriptome-wide modulation of splicing by the exon junction complex. Genome Biol. 15, 551 (2014).","journal-title":"Genome Biol."},{"key":"75243_CR26","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1261\/rna.2186510","volume":"16","author":"TL Crabb","year":"2010","unstructured":"Crabb, T. L., Lam, B. J. & Hertel, K. J. Retention of spliceosomal components along ligated exons ensures efficient removal of multiple introns. RNA 16, 1786\u20131796 (2010).","journal-title":"RNA"},{"key":"75243_CR27","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1086\/342099","volume":"71","author":"K Takahara","year":"2002","unstructured":"Takahara, K. et al. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a <em>COL5A1<\/em> acceptor-site mutation that results in abnormal Pro-\u03b11(V) N-propeptides and Ehlers-Danlos syndrome type I.  Am. J. Hum. Genet. 71, 451\u2013465 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"75243_CR28","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/hmg\/ddl132","volume":"15","author":"X Lin","year":"2006","unstructured":"Lin, X. et al. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet. 15, 2087\u20132097 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"75243_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15171-6","volume":"11","author":"AD Tang","year":"2020","unstructured":"Tang, A. D. et al. Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns. Nat. Commun. 11, 1438 (2020).","journal-title":"Nat. Commun."},{"key":"75243_CR30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1085\/jgp.201010526","volume":"136","author":"JD Lueck","year":"2010","unstructured":"Lueck, J. D., Rossi, A. E., Thornton, C. A., Campbell, K. P. & Dirksen, R. T. Sarcolemmal-restricted localization of functional ClC-1 channels in mouse skeletal muscle. J. Gen. Physiol. 136, 597\u2013613 (2010).","journal-title":"J. Gen. Physiol."},{"key":"75243_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0006-3495(94)80753-2","volume":"66","author":"M Pusch","year":"1994","unstructured":"Pusch, M., Steinmeyer, K. & Jentsch, T. J. Low single channel conductance of the major skeletal muscle chloride channel, ClC-1. Biophys. J. 66, 149\u2013152 (1994).","journal-title":"Biophys. J."},{"key":"75243_CR32","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1152\/physrev.1985.65.2.310","volume":"65","author":"R R\u00fcdel","year":"1985","unstructured":"R\u00fcdel, R. & Lehmann-Horn, F. Membrane changes in cells from myotonia patients. Physiol. Rev. 65, 310\u2013356 (1985).","journal-title":"Physiol. Rev."},{"key":"75243_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1113\/jphysiol.1971.sp009667","volume":"219","author":"SH Bryant","year":"1971","unstructured":"Bryant, S. H. & Morales-Aguilera, A. Chloride conductance in normal and myotonic muscle fibres and the action of monocarboxylic aromatic acids. J. Physiol. 219, 367\u2013383 (1971).","journal-title":"J. Physiol."},{"key":"75243_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/mus.20295","volume":"32","author":"E Colding-J\u00f8rgensen","year":"2005","unstructured":"Colding-J\u00f8rgensen, E. Phenotypic variability in myotonia congenita. Muscle Nerve 32, 19\u201334 (2005).","journal-title":"Muscle Nerve"},{"key":"75243_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1001\/archneur.1975.00490450055007","volume":"32","author":"RL Barchi","year":"1975","unstructured":"Barchi, R. L. Myotonia. An evaluation of the chloride hypothesis. Arch. Neurol. 32, 175\u2013180 (1975).","journal-title":"Arch. Neurol."},{"key":"75243_CR36","doi-asserted-by":"publisher","unstructured":"Davenport, M. L. et al. Differential pathology and susceptibility to MBNL loss across muscles in myotonic dystrophy mouse models. JCI Insight 10, https:\/\/doi.org\/10.1172\/jci.insight.195836 (2025).","DOI":"10.1172\/jci.insight.195836"},{"key":"75243_CR37","doi-asserted-by":"publisher","first-page":"6171","DOI":"10.1113\/JP286636","volume":"602","author":"JH Myers","year":"2024","unstructured":"Myers, J. H., Denman, K., Dupont, C., Foy, B. D. & Rich, M. M. Reduced K(+) build-up in t-tubules contributes to resistance of the diaphragm to myotonia. J. Physiol. 602, 6171\u20136188 (2024).","journal-title":"J. Physiol."},{"key":"75243_CR38","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1002\/emmm.201303275","volume":"5","author":"KY Lee","year":"2013","unstructured":"Lee, K. Y. et al. Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol. Med. 5, 1887\u20131900 (2013).","journal-title":"EMBO Mol. Med."},{"key":"75243_CR39","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","volume":"289","author":"A Mankodi","year":"2000","unstructured":"Mankodi, A. et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289, 1769\u20131772 (2000).","journal-title":"Science"},{"key":"75243_CR40","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/hmg\/ddp058","volume":"18","author":"RJ Osborne","year":"2009","unstructured":"Osborne, R. J. et al. Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum. Mol. Genet. 18, 1471\u20131481 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"75243_CR41","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/hmg\/ddac254","volume":"32","author":"MA Hale","year":"2022","unstructured":"Hale, M. A., Bates, K., Provenzano, M. & Johnson, N. E. Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development. Hum. Mol. Genet. 32, 1413\u20131428 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"75243_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3727\/000000006781510705","volume":"13","author":"A Botta","year":"2007","unstructured":"Botta, A. et al. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2. Gene Expr. 13, 339\u2013351 (2007).","journal-title":"Gene Expr."},{"key":"75243_CR43","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/hmg\/ddy432","volume":"28","author":"ET Wang","year":"2019","unstructured":"Wang, E. T. et al. Transcriptome alterations in myotonic dystrophy skeletal muscle and heart. Hum. Mol. Genet. 28, 1312\u20131321 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"75243_CR44","doi-asserted-by":"publisher","first-page":"955753","DOI":"10.3389\/fmolb.2022.955753","volume":"9","author":"M Braun","year":"2022","unstructured":"Braun, M., Shoshani, S. & Tabach, Y. Transcriptome changes in DM1 patients\u2019 tissues are governed by the RNA interference pathway. Front. Mol. Biosci. 9, 955753 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"75243_CR45","doi-asserted-by":"publisher","first-page":"1007331","DOI":"10.3389\/fcell.2022.1007331","volume":"10","author":"V Todorow","year":"2022","unstructured":"Todorow, V., Hintze, S., Schoser, B. & Meinke, P. Nuclear envelope transmembrane proteins involved in genome organization are misregulated in myotonic dystrophy type 1 muscle. Front. Cell Dev. Biol. 10, 1007331 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"75243_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20063-w","volume":"11","author":"MJ Petrany","year":"2020","unstructured":"Petrany, M. J. et al. Single-nucleus RNA-seq identifies transcriptional heterogeneity in multinucleated skeletal myofibers. Nat. Commun. 11, 6374 (2020).","journal-title":"Nat. Commun."},{"key":"75243_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57487-1","volume":"16","author":"AS Ham","year":"2025","unstructured":"Ham, A. S. et al. Single-nuclei sequencing of skeletal muscle reveals subsynaptic-specific transcripts involved in neuromuscular junction maintenance. Nat. Commun. 16, 2220 (2025).","journal-title":"Nat. Commun."},{"key":"75243_CR48","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1172\/JCI0215417","volume":"109","author":"H Wu","year":"2002","unstructured":"Wu, H. & Olson, E. N. Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice. J. Clin. Invest. 109, 1327\u20131333 (2002).","journal-title":"J. Clin. Invest."},{"key":"75243_CR49","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1093\/nar\/gkab022","volume":"49","author":"MK Tanner","year":"2021","unstructured":"Tanner, M. K., Tang, Z. & Thornton, C. A. Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy. Nucleic Acids Res. 49, 2240\u20132254 (2021).","journal-title":"Nucleic Acids Res."},{"key":"75243_CR50","doi-asserted-by":"publisher","unstructured":"Todorow, V., Hintze, S., Schoser, B. & Meinke, P. Comparative analysis of splicing alterations in three muscular dystrophies. Biomedicines 13, https:\/\/doi.org\/10.3390\/biomedicines13030606 (2025).","DOI":"10.3390\/biomedicines13030606"},{"key":"75243_CR51","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/s43587-023-00480-4","volume":"3","author":"C Anerillas","year":"2023","unstructured":"Anerillas, C. et al. The YAP-TEAD complex promotes senescent cell survival by lowering endoplasmic reticulum stress. Nat. Aging 3, 1237\u20131250 (2023).","journal-title":"Nat. Aging"},{"key":"75243_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/gtc.12201","volume":"20","author":"N Ohsawa","year":"2015","unstructured":"Ohsawa, N., Koebis, M., Mitsuhashi, H., Nishino, I. & Ishiura, S. ABLIM1 splicing is abnormal in skeletal muscle of patients with DM1 and regulated by MBNL, CELF and PTBP1. Genes Cells 20, 121\u2013134 (2015).","journal-title":"Genes Cells"},{"key":"75243_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41380-019-0583-1","volume":"25","author":"MB Clark","year":"2020","unstructured":"Clark, M. B. et al. Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain. Mol. Psychiatry 25, 37\u201347 (2020).","journal-title":"Mol. Psychiatry"},{"key":"75243_CR54","doi-asserted-by":"publisher","unstructured":"Mangin, A. et al. Robust detection of somatic mosaicism and repeat interruptions by long-read targeted sequencing in myotonic dystrophy type 1. Int. J. Mol. Sci. 22. https:\/\/doi.org\/10.3390\/ijms22052616 (2021).","DOI":"10.3390\/ijms22052616"},{"key":"75243_CR55","doi-asserted-by":"publisher","first-page":"108529","DOI":"10.1016\/j.mrrev.2024.108529","volume":"795","author":"R Xu","year":"2025","unstructured":"Xu, R., Zhang, M., Yang, X., Tian, W. & Li, C. Decoding complexity: The role of long-read sequencing in unraveling genetic disease etiologies. Mutat. Res. Rev. Mutat. Res. 795, 108529 (2025).","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"75243_CR56","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/hmg\/ddaa060","volume":"29","author":"RS Yadava","year":"2020","unstructured":"Yadava, R. S. et al. Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3\u2032UTR RNA. Hum. Mol. Genet. 29, 1440\u20131453 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"75243_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature11362","volume":"488","author":"TM Wheeler","year":"2012","unstructured":"Wheeler, T. M. et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488, 111\u2013115 (2012).","journal-title":"Nature"},{"key":"75243_CR58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s43856-025-00733-w","volume":"5","author":"T Weeden","year":"2025","unstructured":"Weeden, T. et al. FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models. Commun. Med. 5, 22 (2025).","journal-title":"Commun. Med."},{"key":"75243_CR59","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0022-510X(83)90135-1","volume":"60","author":"C Torres","year":"1983","unstructured":"Torres, C., Moxley, R. T. & Griggs, R. C. Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy. J. Neurol. Sci. 60, 157\u2013168 (1983).","journal-title":"J. Neurol. Sci."},{"key":"75243_CR60","doi-asserted-by":"publisher","first-page":"114303","DOI":"10.1016\/j.expneurol.2022.114303","volume":"361","author":"X Wang","year":"2023","unstructured":"Wang, X., Dupont, C., Grant, D., Voss, A. A. & Rich, M. M. Plateau potentials contribute to myotonia in mouse models of myotonia congenita. Exp. Neurol. 361, 114303 (2023).","journal-title":"Exp. Neurol."},{"key":"75243_CR61","doi-asserted-by":"publisher","first-page":"803082","DOI":"10.1155\/2012\/803082","volume":"2012","author":"TR Su","year":"2012","unstructured":"Su, T. R., Zei, W. S., Su, C. C., Hsiao, G. & Lin, M. J. The effects of the KCNQ openers retigabine and flupirtine on myotonia in mammalian skeletal muscle induced by a chloride channel blocker. Evid. Based Complement. Altern. Med. 2012, 803082 (2012).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"75243_CR62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.expneurol.2019.02.002","volume":"315","author":"C Dupont","year":"2019","unstructured":"Dupont, C., Denman, K. S., Hawash, A. A., Voss, A. A. & Rich, M. M. Treatment of myotonia congenita with retigabine in mice. Exp. Neurol. 315, 52\u201359 (2019).","journal-title":"Exp. Neurol."},{"key":"75243_CR63","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00424-024-03005-z","volume":"476","author":"C Dupont","year":"2024","unstructured":"Dupont, C., Blake, B., Voss, A. A. & Rich, M. M. BK channels promote action potential repolarization in skeletal muscle but contribute little to myotonia. Pflug. Arch. 476, 1693\u20131702 (2024).","journal-title":"Pflug. Arch."},{"key":"75243_CR64","doi-asserted-by":"publisher","unstructured":"Todorow, V. et al. Transcriptome analysis in a primary human muscle cell differentiation model for myotonic dystrophy type 1. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22168607 (2021).","DOI":"10.3390\/ijms22168607"},{"key":"75243_CR65","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-3-319-49674-0_9","volume":"82","author":"SE Hitchcock-DeGregori","year":"2017","unstructured":"Hitchcock-DeGregori, S. E. & Barua, B. Tropomyosin structure, function, and interactions: a dynamic regulator. Subcell. Biochem 82, 253\u2013284 (2017).","journal-title":"Subcell. Biochem"},{"key":"75243_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-023-00327-x","volume":"13","author":"MR Lambert","year":"2023","unstructured":"Lambert, M. R. & Gussoni, E. Tropomyosin 3 (TPM3) function in skeletal muscle and in myopathy. Skelet. Muscle 13, 18 (2023).","journal-title":"Skelet. Muscle"},{"key":"75243_CR67","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/cm.21629","volume":"77","author":"DK Dube","year":"2020","unstructured":"Dube, D. K. et al. Sarcomeric TPM3 expression in human heart and skeletal muscle. Cytoskeleton 77, 313\u2013328 (2020).","journal-title":"Cytoskeleton"},{"key":"75243_CR68","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1083\/jcb.200406181","volume":"166","author":"AJ Kee","year":"2004","unstructured":"Kee, A. J. et al. Sorting of a nonmuscle tropomyosin to a novel cytoskeletal compartment in skeletal muscle results in muscular dystrophy. J. Cell Biol. 166, 685\u2013696 (2004).","journal-title":"J. Cell Biol."},{"key":"75243_CR69","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41583-023-00742-5","volume":"24","author":"H Ma","year":"2023","unstructured":"Ma, H. et al. Excitation\u2013transcription coupling, neuronal gene expression and synaptic plasticity. Nat. Rev. Neurosci. 24, 672\u2013692 (2023).","journal-title":"Nat. Rev. Neurosci."},{"key":"75243_CR70","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nsmb.1720","volume":"17","author":"H Du","year":"2010","unstructured":"Du, H. et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 17, 187\u2013193 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"75243_CR71","doi-asserted-by":"publisher","first-page":"e1003043","DOI":"10.1371\/journal.pgen.1003043","volume":"8","author":"A Huguet","year":"2012","unstructured":"Huguet, A. et al. Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus. PLoS Genet. 8, e1003043 (2012).","journal-title":"PLoS Genet."},{"key":"75243_CR72","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1212\/WNL.0000000000011002","volume":"96","author":"C Heatwole","year":"2021","unstructured":"Heatwole, C. et al. Mexiletine in myotonic dystrophy type 1: a randomized, double-blind, placebo-controlled trial. Neurology 96, e228\u2013e240 (2021).","journal-title":"Neurology"},{"key":"75243_CR73","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1212\/WNL.0000000000004229","volume":"89","author":"WD Arnold","year":"2017","unstructured":"Arnold, W. D. et al. Open-label trial of ranolazine for the treatment of myotonia congenita. Neurology 89, 710\u2013713 (2017).","journal-title":"Neurology"},{"key":"75243_CR74","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/mus.26372","volume":"59","author":"S Lorusso","year":"2019","unstructured":"Lorusso, S. et al. Open-label trial of ranolazine for the treatment of paramyotonia congenita. Muscle Nerve 59, 240\u2013243 (2019).","journal-title":"Muscle Nerve"},{"key":"75243_CR75","first-page":"Cd004762","volume":"4","author":"J Spillane","year":"2025","unstructured":"Spillane, J. et al. Drug treatment for myotonia. Cochrane Database Syst. Rev. 4, Cd004762 (2025).","journal-title":"Cochrane Database Syst. Rev."},{"key":"75243_CR76","doi-asserted-by":"publisher","unstructured":"Meyer, A. P. et al. Genotype-phenotype correlations and characterization of medication use in inherited myotonic disorders. Front. Neurol. 11 https:\/\/doi.org\/10.3389\/fneur.2020.00593 (2020).","DOI":"10.3389\/fneur.2020.00593"},{"key":"75243_CR77","doi-asserted-by":"publisher","first-page":"e010393","DOI":"10.1161\/JAHA.118.010393","volume":"7","author":"PD Pang","year":"2018","unstructured":"Pang, P. D. et al. CRISPR-mediated expression of the fetal Scn5a isoform in adult mice causes conduction defects and arrhythmias. J. Am. Heart Assoc. 7, e010393 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"75243_CR78","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.ebiom.2015.07.028","volume":"2","author":"J Choi","year":"2015","unstructured":"Choi, J. et al. Muscleblind-like 1 and muscleblind-like 3 depletion synergistically enhances myotonia by altering Clc-1 RNA translation. eBioMedicine 2, 1034\u20131047 (2015).","journal-title":"eBioMedicine"},{"key":"75243_CR79","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"75243_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"75243_CR81","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.03.016","volume":"67","author":"KA Sheth","year":"2018","unstructured":"Sheth, K. A. et al. Muscle strength and size are associated with motor unit connectivity in aged mice. Neurobiol. Aging 67, 128\u2013136 (2018).","journal-title":"Neurobiol. Aging"},{"key":"75243_CR82","unstructured":"Rose, W. Electromyogram analysis, <https:\/\/www1.udel.edu\/biology\/rosewc\/kaap686\/notes\/EMG%20analysis.pdf> (2019)."},{"key":"75243_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3805","volume":"4","author":"L Wei-LaPierre","year":"2013","unstructured":"Wei-LaPierre, L., Carrell, E. M., Boncompagni, S., Protasi, F. & Dirksen, R. T. Orai1-dependent calcium entry promotes skeletal muscle growth and limits fatigue. Nat. Commun. 4, 2805 (2013).","journal-title":"Nat. Commun."},{"key":"75243_CR84","doi-asserted-by":"publisher","first-page":"e0229041","DOI":"10.1371\/journal.pone.0229041","volume":"15","author":"L Encarnacion-Rivera","year":"2020","unstructured":"Encarnacion-Rivera, L., Foltz, S., Hartzell, H. C. & Choo, H. Myosoft: an automated muscle histology analysis tool using machine learning algorithm utilizing FIJI\/ImageJ software. PLoS ONE 15, e0229041 (2020).","journal-title":"PLoS ONE"},{"key":"75243_CR85","doi-asserted-by":"publisher","first-page":"e0240280","DOI":"10.1371\/journal.pone.0240280","volume":"16","author":"G Mazo","year":"2021","unstructured":"Mazo, G. QuickFigures: a toolkit and ImageJ PlugIn to quickly transform microscope images into scientific figures. PLoS ONE 16, e0240280 (2021).","journal-title":"PLoS ONE"},{"key":"75243_CR86","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"75243_CR87","doi-asserted-by":"publisher","first-page":"D916","DOI":"10.1093\/nar\/gkaa1087","volume":"49","author":"A Frankish","year":"2021","unstructured":"Frankish, A. et al. GENCODE 2021. Nucleic Acids Res. 49, D916\u2013d923 (2021).","journal-title":"Nucleic Acids Res."},{"key":"75243_CR88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"75243_CR89","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkz114","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).","journal-title":"Nucleic Acids Res."},{"key":"75243_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2879-1","volume":"20","author":"F Marini","year":"2019","unstructured":"Marini, F. & Binder, H. pcaExplorer: an R\/Bioconductor package for interacting with RNA-seq principal components. BMC Bioinform. 20, 331 (2019).","journal-title":"BMC Bioinform."},{"key":"75243_CR91","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75243-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75243-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75243-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:01:56Z","timestamp":1786924916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75243-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75243"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75243-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.A.T. serves on the Board of Directors of the Myotonic Dystrophy Foundation and receives compensation for service on Scientific Advisory Boards of Dyne Therapeutics and PepGen. The authors declare no other competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8429"}}